Serveur d'exploration sur l'opéra

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Development and Optimization of a Novel 384-Well Anti-Malarial Imaging Assay Validated for High-Throughput Screening

Identifieur interne : 000076 ( PascalFrancis/Checkpoint ); précédent : 000075; suivant : 000077

Development and Optimization of a Novel 384-Well Anti-Malarial Imaging Assay Validated for High-Throughput Screening

Auteurs : Sandra Duffy [Australie] ; Vicky M. Avery [Australie]

Source :

RBID : Pascal:12-0288826

Descripteurs français

English descriptors

Abstract

With the increasing occurrence of drug resistance in the malaria parasite, Plasmodium falciparum, there is a great need for new and novel anti-malarial drugs. We have developed a 384-well, high-throughput imaging assay for the detection of new anti-malarial compounds, which was initially validated by screening a marine natural product library, and subsequently used to screen more than 3 million data points from a variety of compound sources. Founded on another fluorescence-based P. falciparum growth inhibition assay, the DNA-intercalating dye 4',6-diamidino-2-phenylindole, was used to monitor changes in parasite number. Fluorescent images were acquired on the PerkinElmer Opera High Throughput confocal imaging system and analyzed with a spot detection algorithm using the Acapella data processing software. Further optimization of this assay sought to increase throughput, assay stability, and compatibility with our high-throughput screening equipment platforms. The assay typically yielded Z'-factor values of 0.5-0.6, with signal-to-noise ratios of 12.


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:12-0288826

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Development and Optimization of a Novel 384-Well Anti-Malarial Imaging Assay Validated for High-Throughput Screening</title>
<author>
<name sortKey="Duffy, Sandra" sort="Duffy, Sandra" uniqKey="Duffy S" first="Sandra" last="Duffy">Sandra Duffy</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Discovery Biology, Griffith University</s1>
<s2>Nathan</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Nathan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Avery, Vicky M" sort="Avery, Vicky M" uniqKey="Avery V" first="Vicky M." last="Avery">Vicky M. Avery</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Discovery Biology, Griffith University</s1>
<s2>Nathan</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Nathan</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">12-0288826</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0288826 INIST</idno>
<idno type="RBID">Pascal:12-0288826</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000087</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000447</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000076</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Development and Optimization of a Novel 384-Well Anti-Malarial Imaging Assay Validated for High-Throughput Screening</title>
<author>
<name sortKey="Duffy, Sandra" sort="Duffy, Sandra" uniqKey="Duffy S" first="Sandra" last="Duffy">Sandra Duffy</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Discovery Biology, Griffith University</s1>
<s2>Nathan</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Nathan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Avery, Vicky M" sort="Avery, Vicky M" uniqKey="Avery V" first="Vicky M." last="Avery">Vicky M. Avery</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Discovery Biology, Griffith University</s1>
<s2>Nathan</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Nathan</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">The American journal of tropical medicine and hygiene</title>
<title level="j" type="abbreviated">Am. j. trop. med. hyg.</title>
<idno type="ISSN">0002-9637</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">The American journal of tropical medicine and hygiene</title>
<title level="j" type="abbreviated">Am. j. trop. med. hyg.</title>
<idno type="ISSN">0002-9637</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antimalarial</term>
<term>Medical screening</term>
<term>Optimization</term>
<term>Parasiticide</term>
<term>Tropical medicine</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Optimisation</term>
<term>Antipaludique</term>
<term>Dépistage</term>
<term>Médecine tropicale</term>
<term>Antiparasitaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">With the increasing occurrence of drug resistance in the malaria parasite, Plasmodium falciparum, there is a great need for new and novel anti-malarial drugs. We have developed a 384-well, high-throughput imaging assay for the detection of new anti-malarial compounds, which was initially validated by screening a marine natural product library, and subsequently used to screen more than 3 million data points from a variety of compound sources. Founded on another fluorescence-based P. falciparum growth inhibition assay, the DNA-intercalating dye 4',6-diamidino-2-phenylindole, was used to monitor changes in parasite number. Fluorescent images were acquired on the PerkinElmer Opera High Throughput confocal imaging system and analyzed with a spot detection algorithm using the Acapella data processing software. Further optimization of this assay sought to increase throughput, assay stability, and compatibility with our high-throughput screening equipment platforms. The assay typically yielded Z'-factor values of 0.5-0.6, with signal-to-noise ratios of 12.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0002-9637</s0>
</fA01>
<fA02 i1="01">
<s0>AJTHAB</s0>
</fA02>
<fA03 i2="1">
<s0>Am. j. trop. med. hyg.</s0>
</fA03>
<fA05>
<s2>86</s2>
</fA05>
<fA06>
<s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Development and Optimization of a Novel 384-Well Anti-Malarial Imaging Assay Validated for High-Throughput Screening</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>DUFFY (Sandra)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>AVERY (Vicky M.)</s1>
</fA11>
<fA14 i1="01">
<s1>Discovery Biology, Griffith University</s1>
<s2>Nathan</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA20>
<s1>84-92</s1>
</fA20>
<fA21>
<s1>2012</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>6817</s2>
<s5>354000508308850180</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>29 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>12-0288826</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>The American journal of tropical medicine and hygiene</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>With the increasing occurrence of drug resistance in the malaria parasite, Plasmodium falciparum, there is a great need for new and novel anti-malarial drugs. We have developed a 384-well, high-throughput imaging assay for the detection of new anti-malarial compounds, which was initially validated by screening a marine natural product library, and subsequently used to screen more than 3 million data points from a variety of compound sources. Founded on another fluorescence-based P. falciparum growth inhibition assay, the DNA-intercalating dye 4',6-diamidino-2-phenylindole, was used to monitor changes in parasite number. Fluorescent images were acquired on the PerkinElmer Opera High Throughput confocal imaging system and analyzed with a spot detection algorithm using the Acapella data processing software. Further optimization of this assay sought to increase throughput, assay stability, and compatibility with our high-throughput screening equipment platforms. The assay typically yielded Z'-factor values of 0.5-0.6, with signal-to-noise ratios of 12.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B05</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B02S06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Optimisation</s0>
<s5>07</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Optimization</s0>
<s5>07</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Optimización</s0>
<s5>07</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Antipaludique</s0>
<s5>08</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Antimalarial</s0>
<s5>08</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Antipalúdico</s0>
<s5>08</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Dépistage</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Medical screening</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Descubrimiento</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Médecine tropicale</s0>
<s5>13</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Tropical medicine</s0>
<s5>13</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Medicina tropical</s0>
<s5>13</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Antiparasitaire</s0>
<s5>30</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Parasiticide</s0>
<s5>30</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Antiparasitario</s0>
<s5>30</s5>
</fC03>
<fN21>
<s1>219</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Duffy, Sandra" sort="Duffy, Sandra" uniqKey="Duffy S" first="Sandra" last="Duffy">Sandra Duffy</name>
</noRegion>
<name sortKey="Avery, Vicky M" sort="Avery, Vicky M" uniqKey="Avery V" first="Vicky M." last="Avery">Vicky M. Avery</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000076 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000076 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Musique
   |area=    OperaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:12-0288826
   |texte=   Development and Optimization of a Novel 384-Well Anti-Malarial Imaging Assay Validated for High-Throughput Screening
}}

Wicri

This area was generated with Dilib version V0.6.21.
Data generation: Thu Apr 14 14:59:05 2016. Site generation: Thu Jan 4 23:09:23 2024